A History of Rigorous Science and Technological Advancements

Milestones achieved by the Company

  • Secured private, seed, and follow-on investments for product development
  • Received numerous peer-reviewed grant awards from the Juvenile Diabetes Research Foundation (JDRF), National Institutes of Health (NIH), the National Institute of Standards and Technology’s Advanced Technology Program (NIST-ATP), the U.S. Army’s Technologies for Metabolic Monitoring (TMM) Program, and the State of California’s Technology Investment Partnership (CalTIP) program
  • Established FDA-compliant quality system
  • Demonstrated effective glucose sensor functionality¬†in vitro
  • Developed and demonstrated biocompatible materials in animal implants
  • Developed and validated an implantable platform for sensor introduction
  • Developed and validated implantable wireless telemetry
  • Demonstrated successful fully implanted, long term wireless glucose monitoring in diabetic and non-diabetic animals
  • Developed a portfolio of significant intellectual property
  • Satisfied comprehensive preclinical product development requirements
  • Secured medical device manufacturer license
  • Secured FDA clearance for human clinical investigation
  • Completed pilot human clinical implant trial of first generation system